Indian-Made Opioids Fuel West Africa’s Growing ‘Zombie Drug’ Crisis

A new international investigative report has revealed that powerful opioid medicines manufactured by some Indian pharmaceutical companies are worsening the drug crisis across West Africa.

According to the report, millions of dollars’ worth of high-potency painkillers containing tapentadol are being exported from India to several West African countries. Many of these drugs are reportedly entering illegal markets outside legitimate medical systems.

The investigation says the opioids are being mixed with “Kush,” a dangerous street drug widely used in parts of Africa. The deadly combination is locally known as a “zombie drug” because of its severe effects on users, including extreme addiction, mental disorientation, and a high risk of death.

Experts warn that the growing opioid crisis is driving rising addiction rates and overdose deaths among young people in countries such as Nigeria, Sierra Leone, and Ghana.

Health officials in Sierra Leone say the drug epidemic has left many people unconscious on the streets, while fatalities linked to opioid and Kush abuse continue to increase. Rehabilitation centers in some areas have reported that a large number of admitted patients were addicted to opioid-based Kush mixtures.

The India government had previously imposed restrictions on the export of certain opioid combinations. However, the investigation claims that the market remains active through the export of standalone tapentadol tablets.

Specialists have warned that unless the illegal flow of these drugs is stopped, West Africa’s opioid crisis could escalate into a far more serious public health emergency.

The findings have intensified international concern over the illegal spread of Indian-manufactured opioids and their role in fueling the deadly “zombie drug” crisis in Africa.